09-01-2020 19:00 via medpagetoday.com

High Conversion Rate for Conservative Therapy in TNBC

]]>(MedPage Today) -- Half of women with triple-negative breast cancer (TNBC) ineligible for breast-conserving therapy (BCT) converted to BCT eligibility following neoadjuvant chemotherapy, a subgroup analysis of a randomized trial showed.Of 141...
Read more »